A Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529
Clinical trial NCT03400995 · COMPLETED
Trial details
- NCT number
- NCT03400995
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-05
- Primary completion
- 2018-02-27
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.